Farkas H & Varga L. (2011). Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency. Dove Medical Press.
Chicago Style (17th ed.) CitationFarkas H and Varga L. Ecallantide Is a Novel Treatment for Attacks of Hereditary Angioedema Due to C1 Inhibitor Deficiency. Dove Medical Press, 2011.
MLA (9th ed.) CitationFarkas H and Varga L. Ecallantide Is a Novel Treatment for Attacks of Hereditary Angioedema Due to C1 Inhibitor Deficiency. Dove Medical Press, 2011.
Warning: These citations may not always be 100% accurate.